boston scientific corp taxus stent is approved to be sold in japan boston scientific corp has received approval from japanese regulators to sell its taxus drug coated stent in japan the company expects to start selling the stent within six weeks after receiving coverage from government administered health plans stents are scaffolds that prop open clogged arteries to relieve chest pains boston scientific would join johnson &amp johnson which since mid has been the only maker of drug coated stents sold in japan boston scientific says it took longer to be approved because japanese regulators required the company to do a japanese specific trial 
